JPMorgan Reports 5.3% Passive Stake In REGENXBIO, 3,560,915 Shares, In SEC Filing
The bank's Schedule 13G lists a September 30, 2026 triggering event and sole voting power over 3,324,340 shares.
JPMorgan Chase holds 5.3% of REGENXBIO's common stock, or 3,560,915 shares, according to a passive ownership filing (Schedule 13G) dated Tuesday. The filing lists September 30, 2026 as the date of the event that triggered it.
What the filing says
JPMorgan Chase files as a parent holding company. The stake sits in J.P. Morgan Securities, JPMorgan Chase Bank, National Association, and J.P. Morgan Investment Management, the filing says.
It has sole voting power over 3,324,340 of the shares and shared voting power over none. The 5.3% is counted on the Rule 13d-3 basis, which includes shares the holder could acquire within 60 days.
The bank certifies that the shares were acquired and are held in the ordinary course of business. It also certifies they were not bought to change or influence control of REGENXBIO.
What it changes
A passive filing carries no stated plan to seek control, so it is a disclosure of ownership rather than an activist move. In Tuesday trading as of 2:07 p.m. ET, REGENXBIO shares were at $7.19, down 7.46% from the prior close of $7.77, for a market value of $513 million.
The filing does not tie that price move to the stake.
What to watch
REGENXBIO will host an investor event at 1:00 p.m. ET on October 20 on sura-vec, its gene therapy for wet age-related macular degeneration, developed with AbbVie. Topline pivotal data are anticipated in the fourth quarter of 2026.
Separately, a Delaware patent suit against Sarepta, over a University of Pennsylvania gene therapy patent licensed to REGENXBIO, was dropped after the parties agreed to end the case.
The next dated event is the October 20 sura-vec investor event.
Sources
- SCHEDULE 13G — JPMORGAN CHASE & CO. re: REGENXBIO Inc. (RGNX) — SEC EDGAR
- Gene Therapy Patent Suit Against Sarepta Comes To Close - Law360 — law360.com
- REGENXBIO to Host Investor Event Highlighting Surabgene Lomparvovec (Sura-vec) in Wet AMD on October 20 — prnewswire.com
